CN106316999A - Preparing method and application for coumarone- 2,3- diketone oxime derivative - Google Patents

Preparing method and application for coumarone- 2,3- diketone oxime derivative Download PDF

Info

Publication number
CN106316999A
CN106316999A CN201610713876.XA CN201610713876A CN106316999A CN 106316999 A CN106316999 A CN 106316999A CN 201610713876 A CN201610713876 A CN 201610713876A CN 106316999 A CN106316999 A CN 106316999A
Authority
CN
China
Prior art keywords
oxo
formaldehyde
benzopyran
alpha
benzofuran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610713876.XA
Other languages
Chinese (zh)
Other versions
CN106316999B (en
Inventor
应立
曾润生
周鹏骏
孙网彬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU CHINASUN SPECIALTY PRODUCTS CO Ltd
Original Assignee
JIANGSU CHINASUN SPECIALTY PRODUCTS CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU CHINASUN SPECIALTY PRODUCTS CO Ltd filed Critical JIANGSU CHINASUN SPECIALTY PRODUCTS CO Ltd
Priority to CN201610713876.XA priority Critical patent/CN106316999B/en
Publication of CN106316999A publication Critical patent/CN106316999A/en
Application granted granted Critical
Publication of CN106316999B publication Critical patent/CN106316999B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A01N43/12Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings condensed with a carbocyclic ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A01N43/38Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

The invention discloses a preparing method and application for coumarone- 2, 3- diketone oxime derivative. The invention uses 3- formylchromone derivatives as the initiator and the raw materials are easy to get with multiple types and the industrial sodium nitrite as the reaction reagent at low cost; products obtained through the invention are diversified and can be widely applied in drug synthesis of bactericide, sanitizer, drugs for Alzheimer's disease treatment, drugs to restrain hepatitis C virus, SIRT1 and cancer cell proliferation in vitro, etc. In addition, for the method disclosed in the invention, reaction is performed in the air, namely room temperature reaction. The target product has high yield coefficient, low pollution, and simple reaction operation and post-processing, which is suitable for industrial production.

Description

The preparation method of a kind of benzofuran-2,3-two ketoximes derivatives and application
Technical field
The invention belongs to the preparing technical field of organic compound, be specifically related to a kind of benzofuran-2,3-bis-ketoxime spreads out Biological preparation method and application.
Background technology
In in the past few decades, people to benzofuran-2, the relevant report of 3-bis-ketoximes derivatives seldom (see: Smith, L. I.; Holmes, R. R. J. Am. Chem. Soc. 1951, 73,4294-4297), its using value Need further to develop.But, benzofuran-2,3-bis-ketoximes derivatives can be converted into benzo furan easily Muttering-2,3-derovatives, this compounds is widely used in various medicine, such as antibacterial, disinfectant, treatment Alzheimer In the synthesis of family name's medicine, suppression hepatitis C virus cytotoxic drug and suppression SIRT1 and cancer cell in vitro hyperproliferation agent etc..
Benzofuran-2,3-derovatives can prepare aurones derivant: has significant bactericidal action;There is anti-gallbladder Alkali esterase active, can effectively treat Alzheimer;There is the activity well suppressing hepatitis C virus, be treatment The drug candidate of hepatitis C;Having suppression SIRT1 and the effect of cancer cell in vitro propagation, wherein SIRT1 is to rely on nicotinoyl The histone deacetylase of amine adenine-dinucleotide (NAD+), phase close with cell proliferation, differentiation, aging, apoptosis and metabolism Close;Thus can as antibacterial, disinfectant and drug use, the chemical structural formula of aurones derivant following (see: Smith, L. I.; Holmes, R. R. J. Am. Chem. Soc. 1951, 73, 4294-4297; Nadri, H. et al. Bioorg. Med. Chem.2010,18, 6360–6366; Manjulatha, K. et al. Bioorg. Med. Chem. Lett. 2012,22, 6160–6165; Haudecoeur, R. et al. J. Med. Chem.2011,54, 5395–5402;Takeuchi, Y.; Choshi, T.; Tomozane, H.; Yoshida, H.; Yamato, M.Chem. Pharm. Bull.1990, 38(8), 2265-2267;Hadj-esfandiari, N. et al. Bioorg. Med. Chem. Lett. 2007. 17).
Existing benzofuran-2, the synthetic route raw material sources difficulty of 3-bis-ketoximes derivatives, with acetic acid for solvent pair Equipment corrosion is big, affect operator greatly.Therefore a kind of raw material sources of searching are simple, meet Green Chemistry requires, reaction The preparation method that mild condition, universality are good is necessary effectively to synthesize benzofuran-2,3-two ketoximes derivatives.
Summary of the invention
It is an object of the invention to provide one and prepare benzofuran-2, the method for 3-bis-ketoximes derivatives, it has raw material Source is simple, reaction condition gentleness, course of reaction environmental protection, post processing simply, productivity advantages of higher.
To achieve the above object of the invention, the technical solution used in the present invention is: one prepares benzofuran-2,3-bis-ketoxime The method of derivant, comprises the following steps: 3-formacyl chromone derivative, sodium nitrite, potassium peroxydisulfate are dissolved in solvent, in React under room temperature, it is thus achieved that benzofuran-2,3-bis-ketoximes derivatives;
Described 3-formacyl chromone derivative is as shown in following chemical structure of general formula:
Wherein R is selected from: the one in alkyl, aryl, alkoxyl, halogen, nitro, amide groups;
Described solvent is selected from: the one in acetonitrile, acetone, acetic acid, water, N,N-dimethylformamide;
Shown in described benzofuran-2,3-two ketoximes derivatives following row chemical structure of general formula:
In technique scheme, described 3-formacyl chromone derivative is selected from 4-oxo-4H-.alpha.-5:6-benzopyran-3-formaldehyde, 4- Oxo-4H-6-fluoro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-chloro-.alpha.-5:6-benzopyran-3-formaldehyde, the bromo-benzene of 4-oxo-4H-6- And pyrans-3-formaldehyde, 4-oxo-4H-6-nitro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-methyl-8-nitro-benzo pyrrole Mutter-3-formaldehyde, 4-oxo-4H-6-chloro-8-nitro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-isopropyl-.alpha.-5:6-benzopyran- 3-formaldehyde, 4-oxo-4H-7-fluoro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-7-chloro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo- 4H-7-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-5-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-first Epoxide-.alpha.-5:6-benzopyran-3-formaldehyde, 1-oxo-1H-benzo [f] chromone-2-formaldehyde, 4-oxo-4H-benzo also [h] benzo pyrrole Mutter-3-formaldehyde, 2-formoxyl-N-(3-formoxyl-4-oxo-4H-.alpha.-5:6-benzopyran-6-base) one in butyramide.
In technique scheme, thin layer chromatography (TLC) is utilized to follow the tracks of reaction until being fully completed.
In technique scheme, in molar ratio, 3-formacyl chromone derivative: sodium nitrite: potassium peroxydisulfate is 1: (1 ~ 4) : (1 ~ 4).
In technique scheme, reaction carries out column chromatography for separation purification processes to product after terminating.
Invention additionally discloses benzofuran-2 prepared according to said method, 3-bis-ketoximes derivatives, can pass through to hydrolyze To benzofuran-2,3-derovatives, natural product aurones derivant can be readily synthesized by Wittig reaction further; Have sterilization, sterilization, anticholinesterase activity (can be used for treat Alzheimer), suppression hepatitis C virus cytotoxic activity, The suppression effect such as SIRT1 and cancer cell in vitro propagation, thus can use as antibacterial, disinfectant and inhibitor medicaments.
The course of reaction of technique scheme is represented by:
Due to the utilization of technique scheme, the present invention compared with prior art has the advantage that
1, the present invention uses 3-formacyl chromone derivative to be starting material, prepares first in the presence of sodium nitrite, potassium peroxydisulfate Obtain product benzofuran-2,3-bis-ketoximes derivatives, there is the advantage that raw material is easy to get, with low cost, product structure kind is many, And equipment, personnel are safe from harm by solvent environment safety.
2, benzofuran-2 of preparing disclosed by the invention, in the method for 3-bis-ketoximes derivatives, reaction is carried out in atmosphere, Reaction condition is gentle, and the response time is short, and the yield of target product is high, and operation and last handling process are simple, are suitable for industry Metaplasia is produced.
3, benzofuran-2 disclosed by the invention, 3-bis-ketoximes derivatives various structures, can directly use, it is particularly possible to Obtain benzofuran-2,3-derovatives by hydrolysis, natural product can be readily synthesized by Wittig reaction further Aurones derivant;Expand its application greatly, also enrich the kind of antibacterial, disinfectant, inhibitor medicaments etc..
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
The synthesis of embodiment one: 2-(oxyimino)-benzofuran-3 (2H)-one
Using 4-oxo-4H-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-.alpha.-5:6-benzopyran-3-formaldehyde (0.174 g, 1.0 mmol), sodium nitrite is added in reaction bulb (0.069 g, 1.0 mmol), potassium peroxydisulfate (0.270 g, 1.0 mmol) and acetone (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 61%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.45 (s, 1H), 7.82 (t, J = 7.4 Hz, 1H), 7.75 (d, J = 7.5 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.33 (t, J = 7.5 Hz, 1H)。
The synthesis of embodiment two: 2-(oxyimino)-5-fluoro-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-fluorine .alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-6-fluoro-.alpha.-5:6-benzopyran-3-formaldehyde (0.192 g, 1.0 mmol), sodium nitrite is added in reaction bulb (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and acetone (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 83%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.52 (s, 1H), 7.68 (td, J = 9.0, 2.8 Hz, 1H), 7.58 (dd, J = 6.9, 2.8 Hz, 1H), 7.52 (dd, J = 9.0, 3.7 Hz, 1H)。
The synthesis of embodiment three: 2-(oxyimino)-5-chloro-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-chloro-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-6-chloro-.alpha.-5:6-benzopyran-3-formaldehyde (0.209 g, 1.0 mmol), sodium nitrite is added in reaction bulb (0.207 g, 3.0 mmol), potassium peroxydisulfate (0.81 g, 3.0 mmol) and acetone (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 86%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.60 (s, 1H), 7.82 (dd, J = 8.8, 2.4 Hz, 1H), 7.76 (d, J = 2.2 Hz, 1H), 7.51 (d, J = 8.8 Hz, 1H)。
The synthesis of embodiment four: 2-(oxyimino)-5-bromo-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-bromo-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-6-bromo-.alpha.-5:6-benzopyran-3-formaldehyde (0.253 g, 1.0 mmol), nitrous acid is added in reaction bulb Sodium (0.276 g, 4.0 mmol), potassium peroxydisulfate (1.08 g, 4 mmol) and acetonitrile (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 84%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.65 (s, 1H), 7.92 (dd, J = 8.7, 1.9 Hz, 1H), 7.86 (d, J = 1.8 Hz, 1H), 7.45 (d, J = 8.7 Hz, 1H)。
The synthesis of embodiment five: 2-(oxyimino)-5-nitro-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-nitro-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-6-nitro-.alpha.-5:6-benzopyran-3-formaldehyde (0.219 g, 1.0 mmol), nitrous acid is added in reaction bulb Sodium (0.138 g, 2.0 mmol), potassium peroxydisulfate (1.08 g, 4.0 mmol) and acetic acid (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 62%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.76 (d, J = 1.2 Hz, 1H), 8.65 (dd, J = 9.0, 2.5 Hz, 1H), 8.49 (d, J = 2.5 Hz, 1H), 7.74 (d, J = 9.1 Hz, 1H)。
The synthesis of embodiment six: 2-(oxyimino)-5-methyl-7-nitro-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-methyl-8-nitro-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is such as Under:
In reaction bulb add 4-oxo-4H-6-methyl-8-nitro-.alpha.-5:6-benzopyran-3-formaldehyde (0.233 g, 1.0 Mmol), sodium nitrite (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.81 g, 3.0 mmol) and water (4 milliliters), room temperature is anti- Should;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 70%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.81 (s, 1H), 8.39 (s, 1H), 8.02 (s, 1H), 2.48 (s, 3H)。
The synthesis of embodiment seven: 2-(oxyimino)-5-chloro-7-nitro-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-chloro-8-nitro-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
Addition 4-oxo-4H-6-chloro-8-nitro-.alpha.-5:6-benzopyran-3-formaldehyde (0.254 g, 1.0 mmol) in reaction bulb, Sodium nitrite (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and DMF (4 millis Rise), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 65%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.95 (s, 1H), 8.60 (d, J = 2.2 Hz, 1H), 8.33 (d, J = 2.2 Hz, 1H)。
The synthesis of embodiment eight: 2-(oxyimino)-5-isopropyl-benzofuran-3 (2H)-one
Using 4-oxo-4H-6-isopropyl-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-6-isopropyl-.alpha.-5:6-benzopyran-3-formaldehyde (0.216 g, 1.0 mmol), Asia is added in reaction bulb Sodium nitrate (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and acetone (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 84%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6):δ 12.49 (s, 1H), 7.68 (dd, J = 8.4, 1.2 Hz, 1H), 7.55 (s, 1H), 7.35 (d, J = 8.5 Hz, 1H), 2.94 (dt,J = 13.6, 6.8 Hz, 1H), 1.18 (d, J = 6.9 Hz, 6H)。
Embodiment nine: 2-(oxyimino)-N-(2-(oxyimino)-3-oxo-2,3-Dihydrobenzofuranes-5- Base) synthesis of butyramide
Using 2-formoxyl-N-(3-formoxyl-4-oxo-4H-.alpha.-5:6-benzopyran-6-base) butyramide, sodium nitrite as raw material, its Reactions steps is as follows:
2-formoxyl-N-(3-formoxyl-4-oxo-4H-.alpha.-5:6-benzopyran-6-base is added in reaction bulb) butyramide (0.259 G, 1.0 mmol), sodium nitrite (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and acetone (4 millis Rise), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 73%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.40 (s, 1H), 11.86 (s, 1H), 10.14 (s, 1H), 8.16 (d, J = 2.0 Hz, 1H), 8.06 (dd, J = 8.9, 2.2 Hz, 1H), 7.44 (d, J = 8.9 Hz, 1H), 2.53 (d, J = 7.6 Hz, 2H), 1.03 (t, J = 7.5 Hz, 3H)。
The synthesis of embodiment ten: 2-(oxyimino)-6-fluoro-benzofuran-3 (2H)-one
Using 4-oxo-4H-7-fluoro-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-7-fluoro-.alpha.-5:6-benzopyran-3-formaldehyde (0.192 g, 1.0 mmol), sodium nitrite is added in reaction bulb (0.207 g, 3.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and acetone (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 81%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.48 (s, 1H), 7.82 (dd, J = 8.5, 5.8 Hz, 1H), 7.44 (dd, J = 9.1, 1.9 Hz, 1H), 7.24 – 7.03 (m, 1H)。
The synthesis of embodiment 11: 2-(oxyimino)-6-chloro-benzofuran-3 (2H)-one
Using 4-oxo-4H-7-chloro-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-7-chloro-.alpha.-5:6-benzopyran-3-formaldehyde (0.209 g, 1.0 mmol), sodium nitrite is added in reaction bulb (0.207 g, 3.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and water (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 76%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.54 (s, 1H), 7.77 (d, J = 8.2 Hz, 1H), 7.70 (d, J = 1.6 Hz, 1H), 7.37 (dd, J = 8.2, 1.6 Hz, 1H)。
The synthesis of embodiment 12: 2-(oxyimino)-6-Mehtoxy-Benzofuran-3 (2H)-one
Using 4-oxo-4H-7-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-7-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde (0.204 g, 1.0 mmol), Asia is added in reaction bulb Sodium nitrate (0.207 g, 3.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and water (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 79%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.56 (s, 1H), 7.64 (d, J = 8.6 Hz, 1H), 7.04 (d, J = 1.2 Hz, 1H), 6.84 (dd, J = 8.5, 1.3 Hz, 1H), 3.91 (s, 3H)。
The synthesis of embodiment 13: 2-(oxyimino)-4-Mehtoxy-Benzofuran-3 (2H)-one
Using 4-oxo-4H-5-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-5-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde (0.204 g, 1.0 mmol), nitrous is added in reaction bulb Acid sodium (0.207 g, 3.0 mmol), potassium peroxydisulfate (0.59 g, 2.0 mmol) and acetonitrile (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 61%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.23 (s, 1H), 7.75 (t, J = 8.3 Hz, 1H), 6.96 (d, J = 8.2 Hz, 1H), 6.89 (d, J = 8.5 Hz, 1H), 3.93 (s, 3H)。
The synthesis of embodiment 14: 2-(oxyimino)-5-Mehtoxy-Benzofuran-3 (2H)-one
Using 4-oxo-4H-6-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
4-oxo-4H-6-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde (0.204 g, 1.0 mmol), nitrous is added in reaction bulb Acid sodium (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.810 g, 3.0 mmol) and acetonitrile (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 63%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.41 (s, 1H), 7.46- 7.41 (m, 2H), 7.25 (dd, J = 2.2, 0.9 Hz, 1H), 3.84 (s, 3H)。
Embodiment 15: 2-(oxyimino)-naphtho-[1,2-b] furan-3(2H) synthesis of-one
Using 4-oxo-4H-benzo, also [h] .alpha.-5:6-benzopyran-3-formaldehyde, sodium nitrite are as raw material, and its reactions steps is as follows:
4-oxo-4H-benzo also [h] .alpha.-5:6-benzopyran-3-formaldehyde (0.224 g, 1.0 mmol), nitrous is added in reaction bulb Acid sodium (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.810 g, 3.0 mmol) and acetonitrile (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 72%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.67 (s, 1H), 8.16 (d, J = 8.1 Hz, 1H), 8.08 (d, J = 8.2 Hz, 1H), 7.88 – 7.79 (m, 1H), 7.74 (t,J = 7.0 Hz, 2H), 7.61 (d, J = 8.5 Hz, 1H)。
The synthesis of embodiment 16: 2-(oxyimino) naphtho-[2,1-b] furan-1 (2H)-one
Using 1-oxo-1H-benzo [f] chromone-2-formaldehyde, sodium nitrite as raw material, its reactions steps is as follows:
1-oxo-1H-benzo [f] chromone-2-formaldehyde (0.224 g, 1.0 mmol), sodium nitrite is added in reaction bulb (0.138 g, 2.0 mmol), potassium peroxydisulfate (0.810 g, 3.0 mmol) and acetonitrile (4 milliliters), room temperature reaction;
TLC follows the tracks of reaction until being fully completed;
The crude by column chromatography that reaction obtains after terminating separates (petroleum ether: ethyl acetate=4:1), obtains target product (productivity 75%).The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 12.56 (s, 1H), 8.60 (d, J = 8.3 Hz, 1H), 8.45 (d, J = 9.0 Hz, 1H), 8.10 (d, J = 8.2 Hz, 1H), 7.90 – 7.75 (m, 1H), 7.66 (d, J = 9.0 Hz, 1H), 7.62 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H)。
Embodiment 17: 2-(1-5-nitro imidazole-2-methylene)-3 (2HThe conjunction of)-benzofuranone (17-4) Become
With 2-hydroxyl imido grpup-3 (2H)-benzofuranone (17-1) is as raw material (embodiment one), and its reactions steps is as follows:
(1) compound 17-1(3 g is added in the reactor), acetic acid (50 milliliters), hydrochloric acid (30 milliliters), reacting by heating;
(2) TLC follows the tracks of reaction until being fully completed;
(3) reactant is cooled to room temperature, filters, with benzene and petroleum ether recrystallization, obtains target product 17-2(productivity 87%).
The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 8.22 (d, J = 9.0 Hz, 1H), 8.10 – 7.90 (m, 2H), 7.78 – 7.70 (m, 1H);
(4) by compound 17-3(0.682 g, 1.7 mmol) it is dissolved in 25 milliliters of dry tetrahydrofuran solutions, at 0 DEG C It is slowly added dropwise the hexane solution (1.42 mL, 1.8 mmol) of n-BuLi, stirs 30 minutes.It is subsequently adding 17-2 (0.25 G, 1.7 mmol) tetrahydrofuran solution 15 milliliters, stir after half an hour at 0 DEG C, be heated to boiling, react 5 hours.Will Reactant liquor is poured into water, and is extracted with ethyl acetate, and organic layer washes with water, and anhydrous magnesium sulfate is dried, and concentrates, crude product post layer Analysis (ethyl acetate: normal hexane=2:3) separating-purifying, obtains faint yellow target product 17-4(productivity 76%).The analytical data of product As follows:1H NMR (400 MHz, DMSO-d 6): δ 8.22 (d, J = 9.0 Hz, 1H), 8.10 – 7.90 (m, 2H), 7.81 (s, 1H), 7.78 7.70 (m, 1H), 7.05 (s, 1H), 3.72 (s, 3H), compound 17-4 There is significant bactericidal action.
Embodiment 18: 7-methoxyl group-2-(1-5-nitro imidazole-2-methylene)-3 (2H)-benzofuranone (18-3) synthesis
With 7-methoxyl group-2-hydroxyl imido grpup-3 (2H)-benzofuranone (18-1) is as raw material, and its reactions steps is as follows:
(1) compound 18-1(3.2 g is added in the reactor), acetic acid (50 milliliters), hydrochloric acid (30 milliliters), reacting by heating;
(2) TLC follows the tracks of reaction until being fully completed;
(3) reactant is cooled to room temperature, filters, with benzene and petroleum ether recrystallization, obtains target product 18-2(productivity 84%).
The analytical data of product is as follows:1H NMR (400 MHz, DMSO-d 6): δ 8.22 (d, J = 9.0 Hz, 1H), 8.10 – 7.90 (m, 2H), 7.78 – 7.70 (m, 1H), 3.83 (s, 3H);
(4) by compound 17-3(0.682 g, 1.7 mmol) it is dissolved in 25 milliliters of dry tetrahydrofuran solutions, at 0 DEG C It is slowly added dropwise the hexane solution (1.42 mL, 1.8 mmol) of n-BuLi, stirs 30 minutes.It is subsequently adding 17-2 (0.25 G, 1.7 mmol) tetrahydrofuran solution 15 milliliters, stir after half an hour at 0 DEG C, be heated to boiling, react 5 hours.Will Reactant liquor is poured into water, and is extracted with ethyl acetate, and organic layer washes with water, and anhydrous magnesium sulfate is dried, and concentrates, crude product post layer Analysis (ethyl acetate: normal hexane=2:3) separating-purifying, obtains faint yellow target product 18-3(productivity 72%).The analytical data of product As follows:1H NMR (400 MHz, DMSO-d 6): δ 8.23 (d, J = 9.0 Hz, 1H), 8.12 – 7.90 (m, 2H), 7.80 (s, 1H), 7.80 – 7.70 (m, 1H), 7.05 (s, 1H), 3.86 (s, 3H), 3.70 (s, 3H), compound 18-3 has significant bactericidal action.
Embodiment 19: 1-(2-luorobenzyl)-4-((6-methoxyl group-3-oxo benzofuran-2 (3H)-methylene) Methyl) synthesis of pyridinium chloride salt (19-6)
With 6-methoxyl group-2-hydroxyl imido grpup-3 (2H)-benzofuranone (19-1) is as raw material, and its reactions steps is as follows:
(1) compound 19-1(3.2 g is added in the reactor), acetic acid (50 milliliters), hydrochloric acid (30 milliliters), reacting by heating;
(2) TLC follows the tracks of reaction until being fully completed;
(3) reactant is cooled to room temperature, filters, with benzene and petroleum ether recrystallization, obtains target product 19-2(productivity 79%).Product Analytical data as follows:1H NMR (400 MHz, DMSO-d6): δ 8.22 (d, J = 9.0 Hz, 1H), 8.10- 7.90 (m, 2H), 7.78-7.70 (m, 1H), 3.83 (s, 3H);
(4) by compound 19-3(0.600 g, 1.7 mmol) it is dissolved in 25 milliliters of dry tetrahydrofuran solutions, at 0 DEG C It is slowly added dropwise the hexane solution (1.42 mL, 1.8 mmol) of n-BuLi, stirs 30 minutes.It is subsequently adding 19-2 The tetrahydrofuran solution 15 milliliters of (0.303 g, 1.7 mmol), after stirring half an hour, is heated to boiling, reacts 5 at 0 DEG C Hour.Being poured into water by reactant liquor, be extracted with ethyl acetate, organic layer washes with water, and anhydrous magnesium sulfate is dried, and concentrates, slightly produces Thing column chromatography (ethyl acetate: normal hexane=2:3) separating-purifying, obtains faint yellow target product 19-4(productivity 83%).Product Analytical data is as follows:1H NMR (400 MHz, CDCl3), 8.69 (dd, J = 4.5, 2.0 Hz, 2H), 7.71 (dd, J = 5.0, 1.5 Hz, 2H), 7.70 (d, J = 8.5 Hz, 1H), 6.77 (dd, J = 8.5, 2.1 Hz, 1H), 6.76 (d, J= 2.1 Hz, 1H), 6.67 (s, 1H), 3.95 (s, 3H);
(5) compound 19-4(0.25 g, 1 mmol are added in the reactor) and anhydrous acetonitrile (7 milliliters), it is heated to boiling,
Compound 19-5(0.18 g, 1.2 mmol is added in system), stirring reaction 3 hours.Reaction is cooled to room after terminating Temperature, concentrates, adds 15 ml n-hexanes, filters, and is dried, column chromatography (chloroform: methanol=99:1) separating-purifying, obtains target product 19-6(productivity 90%).The analytical data of product is as follows:1H NMR (DMSO-d 6 , 400 MHz) : δ 9.21 (d, J = 6.0 Hz, 2H), 8.52 (d, J = 6.1 Hz, 2H), 7.75 (d, J = 8.3 Hz, 1H), 7.54–7.44 (m, 5H), 7.16 (d, J = 2.2 Hz, 1H), 7.07 (s, 1H), 6.94 (dd, J = 8.3, 2.2 Hz, 1H), 5.86 (s, 2H), 3.95 (s, 3H), compound 19-6 have anticholinesterase activity, can effectively treat A Er Thatch sea Mo's disease.
Embodiment 20: 2-((N-butyl-1H-indol-3-yl methylene)-4,6-dihydroxy benzofuran-3 (2H)-one (20-4) synthesis
With 4,6-dihydroxy-2-hydroxyl imido grpup-3 (2H)-benzofuranone (20-1) is as raw material, and its reactions steps is as follows:
(1) compound 20-1(3.2 g is added in the reactor), acetic acid (50 milliliters), hydrochloric acid (30 milliliters), reacting by heating;
(2) TLC follows the tracks of reaction until being fully completed;
(3) reactant is cooled to room temperature, filters, with benzene and petroleum ether recrystallization, obtains target product 20-2(productivity 76%).Product Analytical data as follows:1H NMR (400 MHz, DMSO-d 6): δ 16.47 (s, 1H), 10.18 (s, 1H), 8.22 (d, J= 9.0 Hz, 1H), 8.10 – 7.90 (m, 2H), 7.78 – 7.70 (m, 1H), 3.83 (s, 3H);
(4) by compound 20-3(0.760 g, 1.7 mmol) it is dissolved in 25 milliliters of dry tetrahydrofuran solutions, at 0 DEG C It is slowly added dropwise the hexane solution (1.42 mL, 1.8 mmol) of n-BuLi, stirs 30 minutes.It is subsequently adding 20-2 The tetrahydrofuran solution 15 milliliters of (0.306 g, 1.7 mmol), after stirring half an hour, is heated to boiling, reacts 5 at 0 DEG C Hour.Being poured into water by reactant liquor, be extracted with ethyl acetate, organic layer washes with water, and anhydrous magnesium sulfate is dried, and concentrates, slightly produces Thing column chromatography (ethyl acetate: normal hexane=2:3) separating-purifying, obtains faint yellow target product 20-4(productivity 77%).Product Analytical data is as follows:1H NMR (400 MHz, DMSO- d 6 ): δ 10.75 (s, 2H), 8.13 (s, 1H), 7.97 (d, J = 7.7 Hz, 1H), 7.56 (d, J = 7.7 Hz, 1H), 7.25 (t, J = 7.7 Hz, 1H), 7.18 (t, J = 7.7 Hz, 1H), 6.97 (s, 1H), 6.27 (d, J = 1.2 Hz, 1H), 6.08 (d, J = 1.2 Hz, 1H), 4.28 (t, J = 7.2 Hz, 2H), 1.79–1.73 (m, 2H), 1.30–1.24 (m, 2H), 0.88 (t, J=7.2 Hz, 3H), compound 20-4 has the activity well suppressing hepatitis C virus, is treatment hepatitis C Drug candidate.
Embodiment 21: 2-(5-bromo-2-phenol methylene) benzofuran-3 (2H) synthesis of-one (21-2)
Using compound 17-2 as raw material, its reactions steps is as follows:
By compound 21-1(0.758 g, 1.7 mmol) it is dissolved in 25 milliliters of dry tetrahydrofuran solutions, at 0 DEG C slowly The hexane solution (1.42 mL, 1.8 mmol) of dropping n-BuLi, stirs 30 minutes.Be subsequently adding 17-2 (0.252 g, 1.7 mmol) tetrahydrofuran solution 15 milliliters, stir after half an hour at 0 DEG C, be heated to boiling, react 5 hours.Will reaction Liquid is poured into water, and is extracted with ethyl acetate, and organic layer washes with water, and anhydrous magnesium sulfate is dried, and concentrates, crude product column chromatography (ethyl acetate: normal hexane=2:3) separating-purifying, obtains faint yellow target product 21-2(productivity 81%).The analytical data of product is such as Under:1H NMR (400 MHz, CDCl3): d 10.47 (s, 1H), 8.28 (d, J = 2.8 Hz, 1H), 7.71– 7.78 (m, 2H), 7.43 (d, J = 8 Hz, 1H) 7.28 (s, 1H), 7.24–7.20 (m, 2H), 6.92 (d, J =8.8 Hz, 1H), compound 21-2 has suppression SIRT1 and the effect of cancer cell in vitro propagation, and wherein SIRT1 is Depend on the histone deacetylase of nicotinamide adenine dinucleotide (NAD+), with cell proliferation, differentiation, aging, apoptosis and Metabolism is closely related.

Claims (10)

1. benzofuran-2, the preparation method of 3-bis-ketoximes derivatives, it is characterised in that comprise the following steps: by 3-first Acyl group chromone derivative, sodium nitrite, potassium peroxydisulfate are dissolved in solvent, react at room temperature, it is thus achieved that benzofuran-2,3-diketone 9 oxime derivate;
Described 3-formacyl chromone derivative is as shown in following chemical structure of general formula:
Wherein R is selected from: the one in alkyl, aryl, alkoxyl, halogen, nitro, amide groups;
Described solvent is selected from: the one in acetonitrile, acetone, acetic acid, water, N,N-dimethylformamide;
Shown in described benzofuran-2,3-two ketoximes derivatives following row chemical structure of general formula:
Benzofuran-2 the most according to claim 1, the preparation method of 3-bis-ketoximes derivatives, it is characterised in that: by mole Ratio, 3-formacyl chromone derivative: sodium nitrite: potassium peroxydisulfate is 1: (1 ~ 4): (1 ~ 4).
Benzofuran-2 the most according to claim 1, the preparation method of 3-bis-ketoximes derivatives, it is characterised in that: reaction knot After bundle, product is carried out column chromatography for separation purification processes.
Benzofuran-2 the most according to claim 1, the preparation method of 3-bis-ketoximes derivatives, it is characterised in that: described 3- Formacyl chromone derivative selected from 4-oxo-4H-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-fluoro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-chloro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-bromo-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-nitre Base-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-methyl-8-nitro-.alpha.-5:6-benzopyran-3-formaldehyde, the chloro-8-of 4-oxo-4H-6- Nitro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-isopropyl-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-7-fluoro-benzo pyrrole Mutter-3-formaldehyde, 4-oxo-4H-7-chloro-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-7-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-5-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, 4-oxo-4H-6-methoxyl group-.alpha.-5:6-benzopyran-3-formaldehyde, 1-oxo- 1H-benzo [f] chromone-2-formaldehyde, 4-oxo-4H-benzo also [h] .alpha.-5:6-benzopyran-3-formaldehyde, 2-formoxyl-N-(3-formyl Base-4-oxo-4H-.alpha.-5:6-benzopyran-6-base) one in butyramide.
Benzofuran-2 the most according to claim 1, the preparation method of 3-bis-ketoximes derivatives, it is characterised in that: utilize thin Layer chromatography follows the tracks of reaction until being fully completed.
Benzofuran-the 2,3-that the most according to claim 1, prepared by the preparation method of benzofuran-2,3-two ketoximes derivatives Two ketoximes derivatives.
7. benzofuran-2,3-two ketoximes derivatives described in claim 6 is in preparing benzofuran-2,3-derovatives Application.
8. the application in preparation disinfectant of benzofuran-2,3-two ketoximes derivatives described in claim 6.
9. benzofuran-2,3-two ketoximes derivatives application in preparing antibacterial described in claim 6.
10. benzofuran-2,3-two ketoximes derivatives application in preparing inhibitor described in claim 6.
CN201610713876.XA 2016-08-24 2016-08-24 A kind of preparation method and application of two ketoximes derivatives of benzofuran -2,3- Active CN106316999B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610713876.XA CN106316999B (en) 2016-08-24 2016-08-24 A kind of preparation method and application of two ketoximes derivatives of benzofuran -2,3-

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610713876.XA CN106316999B (en) 2016-08-24 2016-08-24 A kind of preparation method and application of two ketoximes derivatives of benzofuran -2,3-

Publications (2)

Publication Number Publication Date
CN106316999A true CN106316999A (en) 2017-01-11
CN106316999B CN106316999B (en) 2019-01-08

Family

ID=57790149

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610713876.XA Active CN106316999B (en) 2016-08-24 2016-08-24 A kind of preparation method and application of two ketoximes derivatives of benzofuran -2,3-

Country Status (1)

Country Link
CN (1) CN106316999B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106397381A (en) * 2016-09-09 2017-02-15 苏州大学 2-alkoxy chromone oxime derivative and preparation method and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106397381A (en) * 2016-09-09 2017-02-15 苏州大学 2-alkoxy chromone oxime derivative and preparation method and application thereof
CN106397381B (en) * 2016-09-09 2019-05-28 苏州大学 2- alkoxy chromone 9 oxime derivate and the preparation method and application thereof

Also Published As

Publication number Publication date
CN106316999B (en) 2019-01-08

Similar Documents

Publication Publication Date Title
Hayakawa et al. 4-Hydroxy-3-methyl-6-phenylbenzofuran-2-carboxylic acid ethyl ester derivatives as potent anti-tumor agents
CN105218621B (en) Dehydroabietic acid benzimidazole Schiff base heterocyclic derivatives with anti-tumor activity and preparation method therefor and application thereof
CN112174989B (en) Preparation method of clenbuterol
CN101020658B (en) Synthesis process of main cyclic quinoline compound
EP2707367B1 (en) Methods for preparing naphthyridines
Meshram et al. Boric acid promoted an efficient and practical synthesis of fused pyrimidines in aqueous media
CN106946972B (en) A kind of ursolic acid derivative with anti-tumor activity and preparation method thereof
CN104163786B (en) A kind of method preparing 5-methyl-3-bromo methyl cycloheptapyridine hydrobromate
CN106967044B (en) The method for preparing r-lipoic acid cholinester halide
CN106316999A (en) Preparing method and application for coumarone- 2,3- diketone oxime derivative
CN104725393A (en) Bergenin derivative as well as preparation method and application thereof
CN106631976A (en) 3-amino-3-hydroxymethyloxindole derivative as well as preparation method and application thereof
CN108191849B (en) Preparation method of anti-epidermal growth factor receptor drug resistance mutation inhibitor, related intermediate and application
CN109320583A (en) A kind of dehydroabietic acid benzimidazole thioether class Hete rocyclic derivatives with anti-tumor activity and its preparation method and application
Song et al. Ag-catalyzed acylation of N-heterocycles in aqueous solution
CN112645880B (en) Synthetic method of enzalutamide
CN107573336A (en) Benzheterocycle carboxamide pyridine ketone derivatives and its production and use
CN106432043B (en) 2,3- indole dione -3-N- alkenyl nitrone derivatives and its synthetic method and application
CN108129367B (en) Construction method for constructing chiral sulfinyl imine alpha-site chiral quaternary carbon, product and application thereof
CN107619398B (en) 2- replaces benzo triazone derivatives and its synthetic method
Feng et al. First total synthesis of isoquinolinone alkaloid marinamide and its methyl ester
Bollini et al. Microwave-assisted rapid and efficient synthesis of C-alkyl imidazoisoquinolinone derivatives
CN110862339A (en) Indole micromolecule compound and preparation method thereof
CA2704649C (en) Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities
CN104592253B (en) Novel synthesis method of temsirolimus

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant